MyGevity Elite

Name: MyGevity Elite
Brand: MyGevity
SKU: MYG-ELITE
Price: 599.00 USD
Availability: InStock

Save 14% now

$599.00 $699.00 / per test

Master Your Genetic Destiny with Elite-Level Insights

Unleash the full potential of your DNA with the MyGevity Elite DNA Kit—offering the most complete genetic testing on the market today, spanning an unparalleled 58 reports, 149 tests and 640 Unique SNPs for ultimate depth and breadth. We make it easy with simple, digestible reports and dedicated coaches to guide you through every insight, ensuring you understand and act on your results effortlessly. This premium at-home testing powerhouse reveals profound, evidence-based truths about your physiology—including early warnings for disease risks like Parkinson's, dementia, Alzheimer’s, macular degeneration, autoimmune conditions, and chronic illnesses before symptoms arise. Analyzed in premier CLIA-certified labs across the US, this kit crafts an elite, all-encompassing strategy for thriving—enabling you to enhance mitochondrial efficiency, combat skin aging, boost athletic recovery, and much more. Private, intuitive, and HIPAA-secured, it's crafted to ignite enduring vitality at every life phase™.

Kit Components: Swab tool, stabilization tube, return shipping label, setup guide.

Report Access: Protected digital dashboard featuring in-depth findings, coaching sessions, and support. Standard processing: 2-3 weeks post-lab arrival.

Bone health Brain Health Cellular Longevity Disease Risk Fitness & Injury Risk Hormones Inflammation Methylation Skin & Hair Aging

Core Advantages:

Uncovers hidden vulnerabilities for proactive defense*

Optimizes nutrient intake and metabolic pathways*

Elevates sleep, cognition, and stress handling genetically*

Reinforces heart function and immune defenses*

Detects vitamin/electrolyte shortfalls for exact corrections*

Harmonizes hormones and cellular aging processes*

Revitalizes skin, hair, bones, and performance metrics*

CLIA Certified Labs

Data Never Sold

GDPR Compliant

In-Depth Breakdown

The Elite DNA Kit examines 58 reports encompassing 149 tests and 640 Unique SNPs through an easy cheek swab, scrutinizing countless genes and variants in each for a thorough, polygenic outlook—eclipsing competitors' narrow single-gene approaches. For brain health, we go beyond mere APOE analysis to incorporate dozens of linked genes for robust evaluations of Alzheimer's, Parkinson's, and TBI risks.

Comprehensive Scope

Covers 58 reports, 149 tests and 640 Unique SNPs via multi-gene scrutiny

Seamless At-Home Process

Quick swab, hassle-free

Bespoke Blueprints

Strategies for diet, fitness, anti-aging, and risk mitigation

Instant Tracking

Real-time sample status from start to finish

Fortress-Level Privacy

HIPAA/GDPR compliant, full encryption, no data trade

Elite Lab Standards

CLIA-certified for pinnacle precision

Universal Compatibility

Effortless access on any device through our responsive interface

HIPAA Compliant

GDPR Compliant

At-Home Testing

Data Never Sold

CLIA Certified Labs

Real-Time Tracking

Study 1

Using Genomic Information to Guide Weight Management

Title:

NIH Working Group Report — Using Genomic Information to Guide Weight Management: From Universal to Precision Treatment

Journal:

Obesity (Silver Spring), Volume 24, Issue 1, pages 14–22, (2016)

Summary:

An official NIH trans-agency working group — drawing on researchers from Stanford, Mount Sinai, Harvard, Brown University, and the National Cancer Institute — formally established the scientific case for using genomic data to personalize weight management. The report concluded that elucidating the molecular basis of individual variability in weight change has the potential to improve treatment outcomes, and called for moving from one-size-fits-all approaches toward precision, genomics-informed interventions.

View Study

Study 2

Genetics of Human Longevity

Title:

The Contextualized Genetics of Human Longevity: JACC Focus Seminar

Journal:

Journal of the American College of Cardiology, Volume 75, Issue 21, pages 2693–2705, (2020)

Summary:

Published in the Journal of the American College of Cardiology — one of the most prestigious cardiovascular journals in medicine — this seminar from the University of Bologna uses centenarians as a scientific model to establish that longevity genes and cardiovascular disease genes are deeply interconnected, representing two sides of the same coin. The authors demonstrate that genetic risk is highly context-dependent, shifting with age, environment, and geography, and that the same allele can be protective or harmful depending on genomic context. Their central argument — that genome-environment interactions must be understood to interpret any individual's disease risk — directly supports the value of comprehensive, personalized DNA profiling.

View Study

Study 3

Genes and Athletic Performance

Title:

Genes and Athletic Performance: The 2023 Update

Journal:

Genes (Basel), Volume 14, Issue 6, page 1235, (2023)

Summary:

This comprehensive 2023 review — from researchers at the University of Stirling, Liverpool John Moores University, and Kazan State Medical University — cataloged 251 DNA polymorphisms associated with athletic performance across endurance, power, and strength categories. Of those, 128 markers were validated in two or more independent studies. The review identifies specific high-confidence genetic variants including ACTN3, PPARGC1A, AMPD1, and PPARA that reliably predict performance traits, providing a well-curated reference map for DNA-based fitness and exercise optimization.

View Study

Study 4

Genetic Testing in Dementia

Title:

Genetic Testing in Dementia — A Medical Genetics Perspective

Journal:

International Journal of Geriatric Psychiatry, Volume 36, Issue 8, pages 1158–1170, (2021)

Summary:

Researchers from the Royal Melbourne Hospital, University of Melbourne, and Monash University conducted a comprehensive review of genetic testing across the major dementia subtypes — including Alzheimer's disease, frontotemporal dementia, vascular dementia, and Parkinson's disease dementia. The review found that incorporating genetic testing into the diagnostic pathway can meaningfully reduce time to diagnosis, and that individuals with early onset (before age 65) are at increased risk of harboring identifiable genetic causes. The authors conclude that genetic testing offers significant value when integrated with appropriate clinical context and counseling.

View Study

Study 5

Cognitive Performance in the Elderly

Title:

High Homocysteine and Epistasis Between MTHFR and APOE: Association with Cognitive Performance in the Elderly

Journal:

Experimental Gerontology, Volume 76, pages 9–16, (2016)

Summary:

Scientists from the Golgi Cenci Foundation and the University of Pavia studied elderly subjects to examine how homocysteine levels and the interaction between MTHFR and APOE gene variants affect cognitive performance. The study found that individuals carrying risk variants in both MTHFR and APOE — combined with elevated homocysteine — showed significantly worse cognitive outcomes, demonstrating that the epistatic interplay between these genes compounds cognitive decline risk. The findings support genetic testing for both variants as part of a comprehensive brain health assessment.

View Study

Have a Question?
Start Here.

View more FAQ's

We believe understanding your health should feel empowering—not overwhelming. That's why we've compiled answers to the most common questions about our DNA Kits, Blood Work, Supplements, Shipping, and Data Privacy—all in one place.

Our flagship offering dissects 640 unique SNPs, 58 reports with 149 tests using polygenic precision, spanning longevity, fitness, skin vitality, and disease forecasts (like APOE-driven neurodegeneration plus myriad genes)—yielding an ultimate blueprint for peak health.*

Register via my.mygevityhealth.com, perform the cheek swab as guided, package and post with our label. Results land in your secure hub within 2-3 weeks.

US-based CLIA processing targets vetted, multi-faceted genetic indicators, delivering layered, credible foresight.

Account